Your search for ganciclovir returned 2 results

Although valganciclovir is an effective CMV prophylactic agent after kidney transplantation, it is associated with significant side effects.

Letermovir is currently marketed under the brand name Prevymis for prophylaxis of CMV infection and disease in adult CMV-seropositive recipients of an allogeneic HSCT.